Markers of senescence?
- 8 March 2002
- journal article
- editorial
- Published by Wiley in The Journal of Pathology
- Vol. 196 (4), 371-373
- https://doi.org/10.1002/path.1073
Abstract
The specific identification of cellular senescence in clinical material has important implications for determining the role of senescence in age‐related pathologies and in neoplasia in certain tumours. One suggested marker of senescence is the histochemical identification of a specific β‐galactosidase enzyme operative at pH 6.0. However, recent data indicate that this enzyme may not be specific for senescence in all tissues and probably represents the expression of endogenous lysosomal acid β‐galactosidase, which is expressed by a variety of differentiated cell types. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Cellular senescence as a tumor-suppressor mechanismTrends in Cell Biology, 2001
- Telomerase and cancer: time to move from a promising target to a clinical realityThe Journal of Pathology, 2001
- Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomasHuman Pathology, 2001
- Tubular Cell Senescence and Expression of TGF-β1 and p21WAF1/CIP1 in Tubulointerstitial Fibrosis of Aging RatsExperimental and Molecular Pathology, 2001
- Cellular senescence and cancerThe Journal of Pathology, 1999
- Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cellsNature, 1998
- Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life spanCurrent Biology, 1998
- Telomerase activity: A biomarker of cell proliferation, not malignant transformationProceedings of the National Academy of Sciences, 1997
- A biomarker that identifies senescent human cells in culture and in aging skin in vivo.Proceedings of the National Academy of Sciences, 1995
- The limited in vitro lifetime of human diploid cell strainsExperimental Cell Research, 1965